HIV Infections Clinical Trials in Baltimore, Maryland

7 studies are recruiting for hiv infections in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

   The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) across diverse clinical settings in the United States. The study will characterize how PrEP is initiated, used, and discontinued in routine …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Chase Brexton Health Care, Baltimore, Maryland

   Locations

   38 in total

   Run by

   Gilead Sciences

   See if you can join NCT07473778 on ClinicalTrials.gov

2. Screen2Prevent (S2P)

   Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digita…

   Stage

   Not phased

   Ages

   14 to 24

   Site

   Johns Hopkins University, Baltimore, Maryland

   Locations

   5 in total

   Run by

   Westat

   See if you can join NCT07728123 on ClinicalTrials.gov

3. A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants

   VH4770359 (also known as GSK4770359) is an antiretroviral compound. This first-in-human study aims to evaluate the safety, tolerability, and pharmacokinetics (PK) of orally administered VH4770359 in healthy participants. The findings from this study will support the design of future clinical studie…

   Stage

   Phase 1

   Ages

   18 to 55

   Site

   GSK Investigational Site, Baltimore, Maryland

   Run by

   ViiV Healthcare

   See if you can join NCT07525544 on ClinicalTrials.gov

4. Skeletal Muscle Energetics and Fatiguability in Older Individuals

   The investigators are studying whether metabolic abnormalities in calf (leg) muscle in older people with and others without HIV are associated with decreased abilities to exercise.

   Stage

   Not phased

   Ages

   60 to 90

   Site

   Johns Hopkins Hospital, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT04142047 on ClinicalTrials.gov

5. A Setting Focus Overdose Prevention Intervention

   A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).

   Stage

   Not phased

   Ages

   18 and older

   Site

   Lighthouse Studies at Peer Point, Baltimore, Maryland

   Run by

   Johns Hopkins Bloomberg School of Public Health

   See if you can join NCT05320835 on ClinicalTrials.gov

6. Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation

   The goal of this clinical trial is to evaluate the effectiveness of a social network intervention to recruit people who inject drugs and their networks for HIV testing and linkage to HIV prevention and treatment services in Maryland. Study aims are to determine the effectiveness of a social network…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Johns Hopkins Hospital, Baltimore, Maryland

   Locations

   2 in total

   Run by

   Johns Hopkins University

   See if you can join NCT06103370 on ClinicalTrials.gov

7. Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)

   This randomized Type 1 hybrid effectiveness-implementation trial (N=186) will evaluate the effectiveness and implementation of a peer-delivered problem solving and behavioral activation intervention for adherence to LAI-PrEP/ART ("Peer Activate-LAI") compared to enhanced treatment as usual (ETAU) f…

   Stage

   Not phased

   Ages

   18 to 88

   Site

   Baltimore Safe Haven, Baltimore, Maryland

   Locations

   2 in total

   Run by

   University of Maryland, Baltimore

   See if you can join NCT06501781 on ClinicalTrials.gov